BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO Trademark

Trademark Overview


On Monday, September 30, 2024, a trademark application was filed for BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO with the United States Patent and Trademark Office. The USPTO has given the BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO trademark a serial number of 79412652. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 11, 2025. This trademark is owned by ONO PHARMACEUTICAL CO., LTD.. The BREAK THROUGH EMBRACE THE CHALLENGE WITH ONO trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes, namely, for cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicines for veterinary purposes for the treatment of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiat...

Beauty salon services; barber shop services; providing bath houses; massage and therapeutic shiatsu massage; chiropractic services; moxibustion; medical treatment of dislocated joints, sprain, bone fractures; bodywork therapy; acupuncture; provision of medical information and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the Internet; provision of medical information relating to benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; advisory services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; provision of information on diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic...
break through embrace the challenge with ono

General Information


Serial Number79412652
Word MarkBREAK THROUGH EMBRACE THE CHALLENGE WITH ONO
Filing DateMonday, September 30, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "BREAK THROUGH" with a rectangle behind it. Beneath is the stylized wording "EMBRACE THE CHALLENGE WITH ONO".
Goods and ServicesAnti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes, namely, for cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicines for veterinary purposes for the treatment of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; anesthetic for surgical purposes, sedative and analgesic drugs; vaccines; reagent paper for medical purposes; vitamin preparations; candy, medicated; cough pastilles for pharmaceutical purposes; mint for pharmaceutical purposes; chewing gum for medical purposes; lecithin for medical purposes; greases for medical purposes; cod liver oil; medicinal preparations for the mouth to be applied in the form of capsules; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental sealants, adhesives, amalgams, ceramics, abrasives, cements, alloys, wax, polish; baby diapers; infant diapers; adult diapers; baby diaper covers; infant diaper covers; adult diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powders, pills, capsules, granules, jellies or liquids; dietary supplements for humans; dietary fibre to aid digestion; lyophilized food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies being baby foods; food for babies; nutritional supplements for animals; dietary supplements for animals; semen for artificial insemination
Goods and ServicesBeauty salon services; barber shop services; providing bath houses; massage and therapeutic shiatsu massage; chiropractic services; moxibustion; medical treatment of dislocated joints, sprain, bone fractures; bodywork therapy; acupuncture; provision of medical information and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the Internet; provision of medical information relating to benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; advisory services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; provision of information on diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications via the Internet; online medical counseling services; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of medical information; physical examination services; providing information about diagnostic, prophylactic and therapeutic properties of pharmaceuticals, medical services and health; consultancy services relating to medical services, diagnostic, prophylactic and therapeutic properties of pharmaceuticals, health and dispensing of medications; consultancy, advisory and provision of information relating to weight reduction diet planning, food nutritional intake and health care; consultancy, advisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; animal breeding; veterinary services; beautification for animals, namely, animal grooming; nursing care; rental of medical apparatus and instruments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameONO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, December 19, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 25, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 26, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 20, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Wednesday, May 21, 2025REFUSAL PROCESSED BY MPU
Wednesday, May 21, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 7, 2025REFUSAL PROCESSED BY IB
Thursday, September 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED